Skip to content

FP7

SPRINTT

Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies

Programme
Seventh Framework Programme
Started
Ends
Duration
70 months
Total cost
EUR 56,343,551
EU contribution
EUR 23,999,439
Participants
28 from 11 countries
Topic
FP7_IMI-JU-09-2013-02
Grant agreement
115621

Coordinated by Sanofi-Aventis Recherche & Developpement (FRFrance).

Consortium

EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.

Members of the consortium
OrganisationCountryRoleEU contributionRecognised by
Sanofi-Aventis Recherche & DeveloppementFRFranceCoordinatorNot statedPIC (1.00)
Medizinische Universitat GrazATAustriaParticipantEUR 352,050known name (0.95)
Novartis Pharma AGCHSwitzerlandParticipantNot statedPIC (1.00)
Boehringer Ingelheim InternationalgmbhDEGermanyParticipantNot statedPIC (1.00)
Friedrich-Alexander-Universitaet Erlangen-NuernbergDEGermanyParticipantEUR 1,417,794PIC (1.00)
Universitaetsmedizin Goettingen - Georg-August-Universitaet Goettingen - Stiftung Oeffentlichen RechtsDEGermanyParticipantEUR 1,513,500PIC (1.00)
Servicio Madrileno de SaludESSpainParticipantEUR 2,146,723known name (0.97)
Helsingin YliopistoFIFinlandParticipantEUR 1,113,795known name (0.95)
Biophytis SAFRFranceParticipantNot statedPIC (1.00)
Centre Hospitalier Universitaire de ToulouseFRFranceParticipantEUR 2,247,516known name (0.95)
Institut de Recherches Internationales ServierFRFranceParticipantNot statedPIC (1.00)
Université Paris DescartesFRFranceParticipantEUR 368,980known name (0.95)
Aston UniversityGBUnited KingdomParticipantEUR 715,300known name (0.95)
Diabetes Frail LimitedGBUnited KingdomParticipantEUR 1,388,298PIC (1.00)
Eli Lilly and Company LtdGBUnited KingdomParticipantNot statedPIC (1.00)
Glaxosmithkline Research & Development LimitedGBUnited KingdomParticipantNot statedPIC (1.00)
Niche Science & Technology LtdGBUnited KingdomParticipantNot statedPIC (1.00)
Haskoli IslandsISIcelandParticipantEUR 349,650PIC (1.00)
Caretek SRLITItalyParticipantEUR 2,450,000PIC (1.00)
EU-Open SRLITItalyParticipantEUR 501,841PIC (1.00)
Istituto Nazionale di Riposo e Cura Per Anziani InrcaITItalyParticipantEUR 1,670,125PIC (1.00)
Universita Cattolica del Sacro CuoreITItalyParticipantEUR 4,331,715known name (0.95)
Universita Degli Studi di FirenzeITItalyParticipantEUR 253,290known name (0.95)
Universita Degli Studi di ParmaITItalyParticipantEUR 650,000known name (0.95)
Astellas Pharma Europe BVNLNetherlandsParticipantNot statedPIC (1.00)
Roessingh Research and Development BVNLNetherlandsParticipantEUR 200,046PIC (1.00)
Universiteit MaastrichtNLNetherlandsParticipantEUR 704,088known name (0.95)
Uniwersytet JagiellonskiPLPolandParticipantEUR 867,536known name (0.97)

Changes of the consortium

First seen on with 28 participants from 11 countries.

A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.

Project page on CORDIS (opens in new tab)

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.